Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing tert

Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing tert

US Patent 12048737 · Granted Jul 30, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Identification, optimization and use of cryptic HLA-A24 epitopes for immunothera2014
Identification, optimization and use of cryptic HLA-A24 epitopes for immunothera2014
Use of native peptides and their optimized derivatives for vaccination2014
Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherap2013
Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherap2013
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereo2011
Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic pept2011